March 19 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson’s multiple sclerosis (MS) treatment, Ponvory, the company said on Friday.
The approval was granted to the U.S. drugmaker’s subsidiary Janssen Pharmaceutical Companies. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber)
我们的标准: 汤森路透“信任原则”